Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
MDMA optimizes brain chemistry for safety, openness, and compassion. AEDP uses relational interventions to enhance MDMA's effects in trauma therapy, fostering trust, intimacy, and healing attachment.
Kari Gleiser
Psilocybin service center facilitator discusses ceremonies and natural medicines in Colorado and Oregon's new state frameworks for participation in natural medicine practices.
William Wildcat Coakee, Sean McAllister, Dave Kopilak
Psychedelic-assisted therapy field emphasizes establishing trust, safety, and reputability through professional guidelines, standards, and certification systems. Session discusses current developments in certification requirements and supportive infrastructure.
Brigadier General (Ret) Stephe…, Natalie Gukasyan, Shannon Carlin, Will Van Derveer
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Internal Family Systems (IFS) therapy, developed over four decades, offers evidence-based techniques to guide clients towards Self, fostering inner clarity and compassion. IFS provides a safe and healing map for
Richard Schwartz
Lauren Taus, a psychedelic assisted therapist, discusses a new approach to drugs, family, and healing in therapy sessions and educational programs at Inbodied Life.
Sandell and colleagues discuss the benefits and risks of experiential training in psychedelic therapy for therapists, including potential therapeutic and theoretical functions, as well as risks like dual relationships and
Emma Hapke, Daniel Rosenbaum
Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.
Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou
Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.
Ingmar Gorman, Erika Dyck, Tehseen Noorani